This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a chiral building block in the creation of drugs targeting central nervous system disorders, such as depression, anxiety, and other neurological conditions. Its structural features, including the difluorophenyl group, enhance its ability to interact with specific biological receptors, improving drug efficacy and selectivity. Additionally, it is employed in the study of enzyme inhibition and receptor binding assays to better understand pharmacological mechanisms. Its hydrochloride salt form ensures stability and solubility, making it suitable for formulation and preclinical studies.